Table 2.
Demographic characteristics of the included papers
| Study ID | Year | Surface modification agent | Sample type utilised | Implantation location | Study duration |
|---|---|---|---|---|---|
| Bae et al. [14] | 2018 | Type I Collagen/GA | Rat | Tibia | 84 weeks |
| Barros et al. [15] | 2009 | Bioactive peptide | Dog | Mandible | 8 weeks |
| Cardoso et al. [16] | 2017 | PPL10BMP | Pig | Parietal bone | 4, 8 weeks |
| Cecconi et al. [17] | 2014 | Type I Collagen/Apatite | Rabbit | Femur | 7 weeks |
| Cho et al. [18] | 2019 | Vitronectin-derived peptide | Rabbit | Tibiae | 2 weeks |
| Cho W et al. [19] | 2021 | Type I Collagen/GA | Dog | Jaw | 8 weeks |
| Lutz et al. [20] | 2010 | Biomimetic active peptide (P-15) | Pig | Forehead region | 2 and 4 weeks |
| Pang et al. [21] | 2021 | BMP-2 + HA | Rabbit | Tibiae | 4 weeks |
| Yoo et al. [22] | 2015 | rhBMP-2/PLGA | Rabbit | Tibiae | 3 and 7 weeks |